Sarcopenia in acute ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at muscle loss (sarcopenia) in people who have had an acute ischemic stroke. It aims to understand how muscle wasting affects recovery, which may help improve care for stroke patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older
- You had an acute ischemic stroke confirmed by a CT or MRI scan
- You arrive at the hospital within 72 hours of the stroke
- You are able to give written consent and have a phone for follow-up
- You do not have major limb amputation, severe contractures, stage IV cancer, long-term steroid use, or certain other conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how thigh muscle thickness measured by ultrasound relates to muscle weakness and fear of movement in people who have had a stroke. It may help find better ways to assess muscle health and recovery.
This study looks at how quickly older adults lose muscle strength and mass while hospitalized for a sudden medical illness. It may help find ways to prevent or treat this muscle loss.
This study looks at muscle loss (sarcopenia) in people with multiple sclerosis. It aims to understand what factors are linked to muscle loss, which could help improve care.
This trial studies whether a structured exercise and nutrition program can improve muscle health in older adults with (pre)sarcopenia, especially those who may have slower walking or reduced strength. It also checks safety by excluding people with unstable health problems and several specific medical conditions.
This study looks for muscle loss (sarcopenia) in older adults with advanced hip osteoarthritis who are waiting for hip replacement surgery. It aims to identify muscle weakness early to improve recovery.
This study looks at the reasons for age-related muscle loss (sarcopenia) in people with heart failure. It may help researchers understand what is causing muscle weakness and how it could be treated in the future.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.